Clinical trial reportThe New England journal of medicinePublished
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma
Regional connection
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Temple Health. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- The New England journal of medicine
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Neoplasm Recurrence, Local; Indenes; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Chemotherapy, Adjuvant; Nephrectomy; Administration, Oral; Infusions, Intravenous; Double-Blind Method
- PubMed ID
- 42384869
- Added to directory
- Source checked